• PYR-41, Inhibitor of Ubiquitin-Activating Enzyme E1: Applied

  2026-04-30

  PYR-41, a potent inhibitor of Ubiquitin-Activating Enzyme E1, enables precise modulation of the ubiquitin-proteasome system, with transformative applications in inflammation, antiviral research, and apoptosis assays. This guide delivers stepwise workflow enhancements and troubleshooting strategies, translating current literature into actionable protocols for bench scientists.

• GPR35-KLF5 Circuitry in DSS-Induced Epithelial Repair

  2026-04-30

  This study reveals how intestinal epithelial cells detect and respond to mucosal injury via the GPR35-KLF5 signaling circuit, which senses tryptophan metabolites and initiates repair in ulcerative colitis models. The findings clarify the molecular logic of repair programming in DSS-induced colitis, informing future approaches to intestinal inflammation research.

• Nocodazole: Microtubule Polymerization Inhibitor for Dynamic

  2026-04-29

  Nocodazole is redefining microtubule dynamics research and cell cycle regulation assays, offering robust, reversible inhibition for reproducible results. Applied workflows leverage its precise action for pathogen entry studies, anticancer drug evaluation, and advanced cytoskeletal interrogation.

• Ultrasound-Enhanced Cu Single-Atom MOFs for Targeted Nanocat

  2026-04-29

  This study presents a copper single-atom-based metal-organic framework (MOF) engineered for ultrasound-enhanced nanocatalytic therapy, demonstrating improved chemodynamic tumor ablation via glutathione depletion and Fenton-like reactive oxygen species generation. The integration of near-infrared fluorescent dye IR-1061 enables precise in vivo imaging and tumor targeting, offering a foundation for more efficient and selective cancer therapeutics.

• BX795: Translating PDK1 Inhibition into Immune and Cancer In

  2026-04-28

  Explore how BX795, a selective PDK1 inhibitor, is redefining translational research at the interface of innate immunity, autophagy, and cancer biology. This thought-leadership article blends mechanistic depth, protocol guidance, and strategic perspectives for researchers navigating the expanding frontiers of kinase signaling and immune modulation.

• Exemestane: Steroidal Aromatase Inhibitor for Precision Assa

  2026-04-28

  Exemestane empowers researchers with robust, irreversible inhibition of cytochrome P450 aromatase, elevating both in vitro and in vivo breast cancer research workflows. Leveraging APExBIO’s high-purity formulation, scientists achieve reproducible estrogen biosynthesis inhibition and streamlined troubleshooting for hormone-dependent cancer assays.

• Vitamin C as an Anticancer and Antiviral Tool: Applied Workf

  2026-04-27

  Leverage high-purity Vitamin C (ascorbic acid) from APExBIO to drive reproducible results in advanced cancer and antiviral organoid models. This guide provides stepwise protocols, troubleshooting strategies, and expert insights for maximizing the translational power of ascorbic acid in next-generation biomedical research.

• GAA Repeat Expansions in FGF14: Insights from SCA27B Systema

  2026-04-27

  This article analyzes a recent systematic review and case report on spinocerebellar ataxia 27B (SCA27B) in a Polish family, highlighting the diagnostic significance of GAA repeat expansions in the FGF14 gene. The findings advance understanding of SCA27B phenotypes, methods for genetic confirmation, and implications for molecular diagnosis in late-onset cerebellar ataxia.

• PPARγ Activation Modulates Macrophage Polarization in IBD Mo

  2026-04-26

  This study demonstrates that activating PPARγ regulates the balance of M1/M2 macrophage polarization, attenuating inflammatory bowel disease (IBD) symptoms via the STAT-1/STAT-6 pathway. The findings provide mechanistic insights into immune modulation in IBD and highlight potential translational targets for metabolic and inflammatory disease research.

• Kupffer Cell Plasticity Drives Immune Landscape in Liver Met

  2026-04-25

  This study uncovers how liver-resident Kupffer cells (KCs) and monocyte-derived macrophages (mo-macs) dynamically contribute to immune suppression in liver metastases. The findings reveal that blocking monocyte recruitment alone is insufficient to deplete immunosuppressive macrophages, highlighting the plasticity and adaptability of KCs under inflammatory conditions and informing future therapeutic strategies.

• Artesunate (SKU B3662): Reliable Ferroptosis Inducer for Can

  2026-04-24

  This article addresses key workflow challenges in cancer cell assays and demonstrates how Artesunate (SKU B3662), an artemisinin derivative from APExBIO, delivers reproducible, data-driven solutions. Drawing on recent literature and validated protocols, it guides researchers in optimizing in vitro studies of cell viability, proliferation, and cytotoxicity with confidence.

• Generating Right Ventricular Cardiomyocytes from hPSCs: New

  2026-04-24

  This study introduces a refined differentiation protocol that enables the specific generation of right ventricular-like cardiomyocytes from human pluripotent stem cells by modulating BMP signaling during mesoderm induction. The work provides essential methodology and phenotypic characterization tools for chamber-specific cardiac disease modeling.

• FK866 (APO866): Precision NAMPT Inhibition in Cancer Researc

  2026-04-23

  FK866 (APO866) empowers researchers to dissect NAD metabolism and induce selective, caspase-independent cell death in hematologic cancers such as AML. With robust solubility profiles and reproducible performance, it is a gold-standard tool for interrogating mitochondrial function, autophagy, and therapeutic resistance.

• EdU Flow Cytometry Assay Kits (Cy5): Workflow and Innovation

  2026-04-23

  EdU Flow Cytometry Assay Kits (Cy5) streamline S-phase DNA synthesis detection by leveraging sensitive click chemistry without harsh denaturation, enabling robust multiplexing and high-throughput cell proliferation analysis. This article unpacks their applied workflow, key experimental parameters, and strategic optimization—bridging bench research and translational impact.

• AO/PI Double Staining Kit: Practical Guide for Viability Ass

  2026-04-22

  The AO/PI Double Staining Kit offers a rapid, dual-fluorescent approach for distinguishing viable, apoptotic, and necrotic cells, addressing key challenges in cell viability and death pathway analysis. This kit is optimal for researchers seeking clear differentiation among cell states in various models, but should not be used for applications outside the validated scope of fluorescent cell staining. For studies requiring alternative detection methods or non-fluorescent workflows, this kit may not be suitable.

16072 records 1/1072 page Next 12345 下5页 Last page